-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bfgd3GxwHJEEzINV3Qw4NpTpTcvxGMculJrG2PuIURQsuDtPd0lUDWQybWM//Mda 01PdPjcXuUJs4E9uu4koAA== 0000899140-07-000945.txt : 20070511 0000899140-07-000945.hdr.sgml : 20070511 20070511112553 ACCESSION NUMBER: 0000899140-07-000945 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070508 FILED AS OF DATE: 20070511 DATE AS OF CHANGE: 20070511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NABI BIOPHARMACEUTICALS CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1225 BUSINESS ADDRESS: STREET 1: 5800 PARK OF COMMERCE BLVD N W STREET 2: STE 322 CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 5619895800 MAIL ADDRESS: STREET 1: 5800 PARK OF COMMERCE BLVD NW STREET 2: STE 322 CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: NABI /DE/ DATE OF NAME CHANGE: 19960405 FORMER COMPANY: FORMER CONFORMED NAME: NORTH AMERICAN BIOLOGICALS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Third Point LLC CENTRAL INDEX KEY: 0001040273 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-04829 FILM NUMBER: 07840708 BUSINESS ADDRESS: STREET 1: 390 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2122247400 MAIL ADDRESS: STREET 1: 390 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 FORMER NAME: FORMER CONFORMED NAME: THIRD POINT MANAGEMENT CO LLC DATE OF NAME CHANGE: 19970602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Loeb Daniel S CENTRAL INDEX KEY: 0001300345 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-04829 FILM NUMBER: 07840709 BUSINESS ADDRESS: BUSINESS PHONE: (212) 224-7400 MAIL ADDRESS: STREET 1: THIRD POINT MANAGEMENT COMPANY L.L.C. STREET 2: 360 MADISON AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 4 1 tpllc_nabi4-051107ex.xml X0202 4 2007-05-08 0 0000072444 NABI BIOPHARMACEUTICALS NABI 0001040273 Third Point LLC 390 PARK AVENUE NEW YORK NY 10022 0 0 0 1 See Remarks Below 0001300345 Loeb Daniel S 390 PARK AVENUE NEW YORK NY 10022 0 0 0 1 See Remarks Below Common Stock, par value $0.01 per share 2007-05-08 4 P 0 350000 5.15 A 6100000 I See footnote Common Stock, par value $0.01 per share 2007-05-08 4 P 0 230000 5.13 A 6330000 I See footnote Common Stock, par value $0.01 per share 2007-05-09 4 P 0 225000 5.25 A 6555000 I See footnote Common Stock, par value $0.01 per share 2007-05-10 4 P 0 135000 5.25 A 6690000 I See footnote Common Stock, par value $0.01 per share 2007-05-10 4 P 0 200000 5.25 A 6890000 I See footnote All securities disclosed in this Form 4 are owned by certain funds (the "Funds") managed by Third Point LLC ("Third Point"). Daniel S. Loeb is the Chief Executive Officer of Third Point. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), Third Point and Mr. Loeb may be deemed to be the beneficial owners of the securities held by the Funds. Third Point and Mr. Loeb hereby disclaim any beneficial ownership of all such securities for purposes of Section 16 of the Act, except to the extent of their indirect pecuniary interest therein. May be deemed to be a member of Section 13(d) "group" owning more than 10% of the issuer's common stock; disclaims beneficial ownership for purposes of Section 13(d) of the Act of shares of such common stock except to the extent reported herein. Exhibit List Exhibit 99.1 - Joint Filer Information THIRD POINT LLC, by DANIEL S. LOEB, Chief Executive Officer, by /s/ Justin Nadler, Attorney-in-Fact 2007-05-10 EX-99 2 n3741011.txt EXHIBIT 99.1 JOINT FILER INFORMATION Exhibit 99.1 Attachment to Form 4 JOINT FILER INFORMATION Name and Address: Daniel S. Loeb 390 Park Avenue New York, NY 10022 Date of Event Requiring Statement: 05/08/07 Issuer and Ticker Symbol: Nabi Biopharmaceuticals (NABI) Relationship to Issuer: (1) Designated Filer: Third Point LLC TABLE I INFORMATION Title of Security: Common Stock Transaction Date 05/08/07 Transaction Code P Amount of Securities and Price 350,000 at $5.15 per share Securities Acquired (A) or Disposed of (D) A Amount of Securities Beneficially Owned Following Reported Transactions 6,100,000 Ownership Form: I Nature of Indirect Beneficial Ownership: (1) Title of Security: Common Stock Transaction Date 05/08/07 Transaction Code P Amount of Securities and Price 230,000 at $5.13 per share Securities Acquired (A) or Disposed of (D) A Amount of Securities Beneficially Owned Following Reported Transactions 6,330,000 Ownership Form: I Nature of Indirect Beneficial Ownership: (1) Title of Security: Common Stock Transaction Date 05/09/07 Transaction Code P Amount of Securities and Price 225,000 at $5.25 per share Securities Acquired (A) or Disposed of (D) A Amount of Securities Beneficially Owned Following Reported Transactions 6,555,000 Ownership Form: I Nature of Indirect Beneficial Ownership: (1) Title of Security: Common Stock Transaction Date 05/10/07 Transaction Code P Amount of Securities and Price 135,000 at $5.25 per share Securities Acquired (A) or Disposed of (D) A Amount of Securities Beneficially Owned Following Reported Transactions 6,690,000 Ownership Form: I Nature of Indirect Beneficial Ownership: (1) Title of Security: Common Stock Transaction Date 05/10/07 Transaction Code P Amount of Securities and Price 200,000 at $5.25 per share Securities Acquired (A) or Disposed of (D) A Amount of Securities Beneficially Owned Following Reported Transactions 6,890,000 Ownership Form: I Nature of Indirect Beneficial Ownership: (1) Signature DANIEL S. LOEB By: /s/ Justin Nadler --------------------------- Name: Justin Nadler Title: Attorney-in-Fact -----END PRIVACY-ENHANCED MESSAGE-----